Pharmaceuticals

New Test Capable of Detecting Clinically Significant Prostate Cancer in Small Blood Sample

* International research team unveils new, pain-free approach to avoid up to 7 in 10 unnecessary prostate biopsies * Simple blood test to boost performance of traditional PSA screening BANGKOK andBASEL, Switzerland, Aug. 6, 2019 /PRNewswire/ -- An international research team at Mahidol Univer...

2019-08-06 16:44 2078

Innovent and Shenogen Announce Collaboration to Evaluate Tyvyt® (Sintilimab injection) in Combination with SNG1005 for the Treatment of Patients with Advanced Cancer

SUZHOU, China, Aug. 6, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced the signing of a collaboration agreement with Shenogen Pharma Group Ltd. ("Shenogen") to ...

2019-08-06 08:00 3569

@BactLAB(TM), Bacterial Colony-counting Service, Now Available Globally

TOKYO, Aug. 5, 2019 /PRNewswire/ -- Nissui Pharmaceutical Co., Ltd., based in Tokyo, is pleased to announce that @BactLAB(TM), an application that uses Amazon Web Service (AWS) Cloud and artificial intelligence (AI) technologies to enable quick and easy counting of bacterial colonies, is now avai...

2019-08-05 13:00 6749

Ascletis Received IND Approval and Management Outlook of 2019 and Beyond

HANGZHOU and SHAOXING, China, Aug. 5, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that it received I...

2019-08-05 08:00 3586

CPhI & P-MEC China 2019 celebrated its 19th edition as a great success

SHANGHAI, Aug. 2, 2019 /PRNewswire/ -- Successfully concluded at Shanghai New International Expo Centre (SNIEC) onJune 20, 2019, CPhI & P-MEC China 2019 achieved its goals of displaying new achievements, igniting collision of new ideas, and out-looking on new trends in the three days and received...

2019-08-02 12:39 2800

Marken Acquires Japanese Logistics Company

Acquisition of PCX Expands the Company's Footprint in Japan RESEARCH TRIANGLE PARK, North Carolina, Aug. 1, 2019 /PRNewswire/ -- Marken announced today the acquisition of PCX International Co. Ltd based in Japan.  PCX operates from theirTokyo headquarters to coordinate the delivery of over 3,0...

2019-08-01 18:00 3492

ERBA Mannheim to Unveil NEXUS Next Generation Automation at AACC 2019

LONDON, Aug.1, 2019 /PRNewswire/ -- * New affordable, modular, mid-scale clinical chemistry, immunoassay and hematology range with sample selection and transport systems, making powerful automation accessible to growing labs * Hematology system uses unique combination of ultra-high defi...

2019-08-01 04:39 1976

MediBeacon Enters into $30 Million Investment and Exclusive Commercialization Partnership in Greater China with Huadong Medicine

MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon's entire portfolio of assets inGreater China ST. LOUIS, July 31, 2019 /PRNewswire/ -- MediBeacon Inc., whose largest shareholder is Pansend Life Sciences, LLC, a subsidiary of HC2 Holdings, Inc. ...

2019-07-31 20:30 3737

Scala and FUTURAMEDIA Drive French Pharmacy Sales with Digital Signage

Point of sale and street-facing Scala-driven digital signage screens increase product sales by up to 80% in thousands of pharmacies acrossFrance SITTARD, The Netherlands, July 30, 2019 /PRNewswire/ -- Scala, part of the STRATACACHE family of digital media/marketing technology companies, has been ...

2019-07-30 17:00 1384

HKSH Medical Group Brings Precision Radiation Medicine to Cancer Patients in Asia With Elekta Unity MR-Linac

HONG KONG, July 30, 2019 /PRNewswire/ -- Elekta Unity, a transformative magnetic resonance radiation therapy (MR/RT) system that enables personalized precision radiation therapy, is in clinical use at HKSH Cancer Centre. The milestone marks the first clinical use of Elekta Unity inAsia. HKSH rec...

2019-07-30 13:47 6048

Internationally Renowned Radiation Oncologist, Prof. Dr. Dattatreyudu Nori Appointed as International Director, Apollo Cancer Centres, Apollo Hospitals Group

NEW DELHI, July 29, 2019 /PRNewswire/ -- Apollo Hospitals have appointed world renowned Radiation Oncologist, Prof. Dr. Dattatreyudu Nori, as International Director – Apollo Cancer Centres, Apollo Hospitals Group. Beginning this month, Dr. Nori will be available for consultations 10 times at Apol...

2019-07-29 22:17 3513

Submission and acceptance of application for the production of new drug for Yisaipu(R)aqueous injection solution

SHANGHAI, July 29, 2019 /PRNewswire/ -- 3SBio Inc. (01530.HK), a leading biopharmaceutical company in the PRC, announces today that an application for the production of new drug has been submitted to the National Medical Products Administration for Yisaipu® pre-filled aqueous injection solution (...

2019-07-29 21:42 5493

NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation

LUND, Sweden, July 28, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the ...

2019-07-28 21:47 5644

Sanofi Announces Participation in 2nd China International Import Expo

SHANGHAI, July 26, 2019 /PRNewswire/ -- At today's Matchmaking Meeting for Medical Devices and Medical Health Care Exhibitors and Buyers of the 2nd China International Import Expo (CIIE), Sanofi officially announced that it would participate in the 2nd CIIE held in the National Convention and Exh...

2019-07-26 21:50 3810

Novartis, Mundipharma ink partnership to enhance access to three Asian countries to established medicine brands for glaucoma and external eye diseases

* Novartis and Mundipharma have signed an agreement for Mundipharma to market, sell and distribute Novartis medicines in the general ophthalmology disease area, including medicines for glaucoma and external eye diseases in Taiwan. This follows recent agreements for the Philippines and Thailand. ...

2019-07-26 12:25 2584

Penta and CROMSOURCE Announce Their Partnership to Improve Paediatric Drug Development

VERONA, Italy, July 25, 2019 /PRNewswire/ -- Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biot...

2019-07-25 19:00 3376

First Patient Dosed in Sintilimab and Anti-VEGF Monoclonal Antibody IBI305 with Chemotherapy in Patients with EGFR-mutant Non-squamous NSCLC who have Progressed from Prior EGFR-TKI Treatment

SUZHOU, China, July 25, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and other major diseases, today announ...

2019-07-25 08:16 3214

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

TIANJIN, China, July 23, 2019 /PRNewswire/ -- In a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in the PIONEER III randomized, controlled clinical trial.  The PIONEER III trial is designed to...

2019-07-23 15:00 2902

Huge CPhI & P-MEC China a direct result of surging manufacturing

SHANGHAI, July 23, 2019 /PRNewswire/ -- CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, andShanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market inChina continues to gr...

2019-07-23 13:18 2315

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

SHANGHAI, July 23, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) inShanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two...

2019-07-23 12:48 3443
1 ... 179180181182183

Week's Top Stories